John Elicker | SVP, Public Affairs and IR |
Giovanni Caforio | Chairman and CEO |
Charlie Bancroft | CFO |
Chris Boerner | Chief Commercial Officer |
Fouad Namouni | Head, Oncology Development |
Tim Anderson | Wolfe research |
Seamus Fernandez | Guggenheim |
Chris Schott | JP Morgan |
Navin Jacob | UBS |
Terence Flynn | Goldman Sachs |
Steve Scala | Cowen |
Matt Phipps | William Blair |
Jason Gerberry | Bank of America |
Umer Raffat | Evercore |
David Risinger | Morgan Stanley |
Good day, and welcome to the Bristol-Myers Squibb 2019 Second Quarter Results Conference Call. Today's conference is being recorded.
At this time, I would like to turn the conference over to Mr. John Elicker, Senior Vice President, Public Affairs and Investor Relations. Please go ahead, sir.